New York, August 01, 2016 -- New York, Aug 1, 2016 -- Moody's Investors Service commented on inVentiv Health's announcement that Advent International will make a significant investment in the company. While Advent's investment does not have a near-term credit impact on inVentiv, it means that the company will not IPO and delays the planned refinancing of the capital structure. There is no change to any of the company's ratings, including the B3 Corporate Family Rating or stable outlook.
Vollständigen Artikel bei Moodys lesen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.